|
Zentiva N.V. - Comparative Business Analysis Snapshot
Business Description
Zentiva N.V.. The Group's principal activities are producing, developing and selling of generic pharmaceuticals, including pharmaceutical chemicals, cosmetics and packaging for pharmaceutical products and special purpose equipment and machines for the pharmaceutical industry. The Group's main operations are based on Czech Republic, Slovak Republic, the Baltic states, Romania, Bulgaria, Moldavia and the Commonwealth of independent states. Some branded pharmaceutical products manufactured by the group include: Helicid, Lozap, Torvacard, Simvacard and Ibalgin. On Mar 5, 2007, the Group signed an agreement to acquire 75% of the issued capital of Eczacibasi Generic Pharmaceuticals, a pharmaceutical company in Turkey.
Competitor Analysis
This analysis compares Zentiva N.V. with three other companies in closely related industry sectors.
The full Comparative Business Report is available to Subscribers or may be purchased individually. The full report generally includes the following sections:
- Sales Analysis: Recent Sales, Sales Growth, Sales per Employee
- Recent Stock Performance
- Company Valuation Ratios: Price/Earnings, Price/Book Value
- Price/Sales and 52 Week Price change
- Dividend Analysis
- Profitability Analysis: Gross Profit Margin, EBITDA Margin
- Earnings Before Extraordinary Items
- Inventory Analysis
- Research and Development Expenses
- Financial Position: Long Term Debt/Equity, Days Accounts Receivable, Days Inventory
- R&D Expenses/Sales
Not the Report you are looking for? Click here for more browsing options.
|
